Can a cosmetic product thicken your hair?

What can an over-the-counter cosmetic 'hair thickening' product actually do for someone with hair loss? Well, as a hair transplant surgeon, I always thought "not much!"  However, I've learned over the years that the right haircare and hairstyling products can be VERY helpful for women with thinning hair and also for some men with thinning hair if they have a medium to longer length hairstyle. At Bauman Medical Group, we developed our own "Bauman-MD" line of haircare products including a sulfate-free, color-safe Shampoo and a lightweight UV protectant Conditioner.  As stand-alone products, or for use in conjunction with FDA-approved hair regrowth medications or devices that act directly on the follicles to produce better hair growth, small improvements in hair fiber 'performance' can certainly have an impact on hair styling, managability and scalp coverage.

In 2011, we began working with Dr. Jeni Thomas and her team from Procter & Gamble's Pantene Institute, testing their AgeDefy Hair Thickening product in a blinded clinical trial on nearly 100 women with thinning hair.  The science supported the action of the product, which was to thicken each individual hair fiber, but what would the results be on our the clinical trial participants after 6 weeks and after 12 weeks?

The results so far have been extremely encouraging, so stay tuned for the final report!  See the video below for more information on Pantene Expert Collection AgeDefy Hair Thickening product.





Watch Tonight @WPBF25News New Device Helps Measure Hair Quality and Quantity

Tune in to watch Dr. Alan Bauman of Bauman Medical Group and Certified HairCoach Lauren Donald, owner of Bond Street Salon in Delray Beach, discuss this latest breakthrough device and the collaboration between hair stylists and doctors to help those with hair loss.

AutoloGel PRP enhances healing after hair transplantation

AutoloGel™ PRP Enhances Healing After Hair Transplantation

Today, more and more doctors performing hair transplantation are using AutoloGel PRP to help wounds heal faster and reduce the cosmetic downtime from a hair transplant procedure. AutoloGel is used to accelerate the body’s recovery mechanisms and create an optimal environment for wound healing to occur comfortably and quickly.

Studies show that a wound needs three elements to heal naturally and quickly:

  • Moisture
  • Nutrients
  • Cellular growth factors and proteins

Once you hair transplant procedure has been completed, Dr. Alan Bauman and his surgical team will apply AutoloGel PRP immediately after transplantation to stimulate the natural healing process. AutoloGel PRP contains an ingredient obtained directly from your blood, called “platelets.”

PRP – platelet rich plasma – helps keep the wound moist like a biologic bandage and delivers the body’s own growth factors and nutrients.  AutoloGel PRP contains activated platelets and promotes natural healing without side effects or risks.

Platelets are crucial to the healing of wounds.  In order for a wound to heal naturally, it must have the growth factors provided by platelets.  PRP harnesses each person’s own natural healing processes, delivering the growth factors and nutrients that help cells grow and new tissue to form.  PRP can restore the balance in the wound environment to help hair transplants heal naturally with less redness, less crusting and less swelling.

Dr. Alan J. Bauman and every member of his hair transplant team have successfully completed the Cytomedix™ AutoloGel System Certification Training on the AutoloGel System for Surgical Hair Restoration as of August 24, 2011.  Dr. Bauman was one of the first hair transplant surgeons in the world to have his entire surgical team certified to offer AutoloGel PRP wound healing.

AutoloGel PRP reduces scalp scabbing, swelling and redness

A study by RJ Reese, shows that patients receiving AutoloGel PRP after hair transplant had improved healing compared to those who did not receive AutoloGel.

All PRP’s are not alike.  Only one is FDA-cleared for wound care: AutoloGel PRP. Because the term PRP can be applied to any platelet rich plasma product, it may be misleading.  PRP products can vary according to their production process and the end results can be vastly different.   There is only one PRP available that is cleared by the U.S. Food and Drug Administration (FDA) for wound care: AutoloGel PRP.  Dr. Alan J. Bauman and the surgical team at Bauman Medical Group is proud to offer the only FDA-approved PRP regimen with every single hair transplant procedure performed. 


Reese RJ, A single-blinded, randomized controlled study of the use of autologous platelet rich plasma (PRP) as a medium to reduce scalp hair transplant adverse events. Hair Transplant Forum Int’l, March/April 2008:pp 51-52.



More evidence suggests heart health & male baldness link

A few years back some studies suggested there was a link between heart disease and male pattern baldness. Today, it seems more information on the relationship between cardiovascular risk and baldness at the top of the head (vertex) is becoming available. Dr. Anne Tybjaerg-Hansen of Copenhagen University Hospital Hair recently presented some new unpublished research on the heart health and baldness connection. Hair has always been a sign of one's health, so here might be one more reason to visit a doctor if you are personally experiencing hair loss or there is a high degree of male pattern baldness in your family. 

Joseph Brownstein (FOX NEWS) reports:

A bald patch on the top of your head or a small vertical crease in your earlobe may seem like relatively harmless signs of aging, but a new study says signs like these may signal an increased risk of heart disease.

Danish researchers found that people were 39 percent more likely to have heart disease, and 57 percent more likely to have a heart attack, if they had at least three of these four signs: baldness on top of the head, receded hairline, a crease in the earlobe, and fatty deposits on the eyelids known as xanthelasmata.

The researchers accounted for people's ages in their results.

Therefore, the study shows "looking old for your age, by [having] these aging signs, marks poor cardiovascular health," said study researcher Dr. Anne Tybjaerg-Hansen, a professor and chief physician in the department of clinical biochemistry at Copenhagen University Hospital.

While the exact reason for the links between these signs and heart disease risk remains unclear, the study "validates the common clinical practice that the clinician examines the patient, and often looks at whether a person looks older or younger for her age," Tybjaerg-Hansen said.

The researchers used data from the Copenhagen Heart Study, which included10,885 people who were over the age of 40. Over the 35-year study, 3,401 participants developed heart disease, and 1,708 had a heart attack. Researchers examined six physical features associated with aging, but found that two — gray hair and wrinkles — did not appear to be linked with increased risk of heart problems.

The study included 5,828 men and 5,057 women. When the researchers considered the genders separately, they found that hair loss in women was not linked with an increased risk of heart disease. However, among the 737 men who had a receding hairline, 82 suffered a heart attack, meaning there a 40 percent higher risk in men with hair loss than those without.

Previous research has looked at whether hair loss may be a warning sign of heart disease, but results have been conflicting. Some studies have linked the severity and type of baldness with the risks of heart disease or heart attacks to varying degrees, but others have found no connection. Because the risk of both heart disease and baldness rise with age, it can be difficult for researchers to separate the two in studies.

Tybjaerg-Hansen said the four signs identified in the new study should give clinicians greater incentive to treat patients who have them. "The suggestion is that lifestyle changes and lipid-lowering therapies should be intensified, because their risk is higher," she said.

However, the area needs more research, because "it would be nice to know why these [varying factors] would be associated with increased risk," she said.

Tybjaerg-Hansen said, for example, that hair loss is linked with levels of testosterone in the blood, so the new study suggests the hormone also plays a role in heart disease, but there's "no hard data there at all, [it's] only speculative."

She said the group for whom the new results would raise the greatest concern is men between ages 70 and 79. In this group, 45 percent of those with all four aging signs developed heart disease, versus 31 percent of those with none of the four.

"This study underscores the importance of doing a good physical exam, in addition to any testing we're going to do for risk for heart disease," said Dr. Nieca Goldberg, director of the NYU Center for Women's Health and American Heart Association spokesperson, in a statement in response to the study.

While the researchers adjusted their results to account for other risk factors for heart disease, Goldberg noted that, for example, xanthelasmata is a sign of high cholesterol levels, a traditional risk factor for heart disease.

Goldberg concluded that while the length of the study made the results compelling, doctors "need to continue to monitor our standard testing for heart disease risk, such as measuring cholesterol, blood pressure, glucose for diabetes."

The researchers are presenting their findings today (Nov. 6) at an American Heart Association research conference. The findings have not been published in a scientific journal.


潘婷CLINICARE丰盈“金萃瓶”:重焕青春活力 赋发丰盈之美 │国际城中时尚│ChicPark of Metropolitan | 有型生活 自在不凡!


I just returned from Beijing, China joining hair scientist, Dr. Jeni Thomas, and the Pantene team to share news of China's new exciting cosmetic hair care product. Over the past year, I've tested this new haircare product on my own patients at Bauman Medical Group and seen its results first hand. It was great to share the work I've done with Pantene and the approximately 100 beauty journalists that attended the event. Stay tuned for more info about a new cosmetic hair product coming soon to the U.S.! #paid  --Dr. Alan J. Bauman, M.D. |  Medical Director | Bauman Medical Group, P.A. | Member, ISHRS | Diplomate, American & International Board of Hair Restoration Surgery

Stem Cells May Hold the Cure for Baldness

TUESDAY, Jan. 4 (HealthDay News/Alan Mozes) -- Common baldness could have its roots in a newly identified stem cell defect, a finding that could potentially lead to new hair-loss treatments down the road, a new study reveals.

Researchers say they discovered that a cellular malfunction short-circuits the process by which hair follicle stem cells turn into hair-producing progenitor cells. That defect, rather than any loss of stem cells themselves, sparks the onset of androgenetic alopecia, the medical term for a type of genetic hair loss that affects both men and women, they report.

In men, this hair loss is commonly known as male pattern baldness, marked by the familiar receding hairline and thinning hair on top of the head -- a condition that sometimes leads to complete baldness. In women, female-pattern hair loss causes the hair to get thinner all over but rarely leads to baldness.
The findings offer "a lot more hope that you could actually get hair to grow in a bald scalp," said study co-author Dr. George Cotsarelis, chairman of the dermatology department at the University of Pennsylvania School of Medicine Cotsarelis.

"Previously we thought the stem cells were gone, and if that was the case it would be very difficult. But because they are present it should be possible to treat," he said.
For their study, the authors collected human scalp tissue -- both bald and haired -- discarded during hair transplant procedures performed on 54 white men who were 40 to 65 years old.
A complex series of analyses revealed that bald and haired tissue contain equivalent amounts of preserved stem cells, which give rise to progenitor cells. Bald tissue, however, did not contain the normal amount of progenitor cells, suggesting a malfunction in the normal behavior of hair follicle stem cells.
"The follicles that make hair don't go away completely, but they become miniaturized, to the point where the hair they normally make to replace hair when it naturally falls out becomes microscopic and therefore invisible," Cotsarelis said.
There are still just as many stem cells in the bald scalp that can make hair as there are in the normal haired scalp, and that was an important and surprising finding, Cotsarelis said
"It caused us to ask, 'If that is the case, why isn't the hair there?'" he said. They found that the progenitor cells, which have the job of making thick hair, are in short supply when baldness occurs "because the stem cells are for some reason blocked or incapable of making these progenitor cells," he said.
Their discovery, reported Jan. 4 in the Journal of Clinical Investigation, might someday lead to new targets for treatment of baldness, which affects millions of people worldwide, they say.
"Now that we have identified the problem we can try to better understand how to get a stem cell to make and activate a progenitor cells. And then we should be able to develop new ways of treating baldness," Cotsarelis said.
Vicki Kalabokes, president and CEO of the National Alopecia Areata Foundation, concurs. (Alopecia areata is a condition that causes round patches of hair loss.)
"There's still a long road ahead here," she cautioned. "But until now it had not been proven that this sort of stem cell defect was perhaps the problem. So this could certainly open up an avenue for future explorations looking into to how to correct this defect."
However, those hoping for a treatment anytime soon will have to wait. "Taking something from the lab to the clinic often takes decades, so there's no treatment around the corner," Cotsarelis cautioned. "It's really going to take quite a while to figure this out."

Read the original article in the Journal of Clinical Investigation

For more information on how to treat hair loss today, visit

Androgen Sensitivity Genetic Test for Women With Hair Loss

Dna Can we better predict off-label treatment success in female hair loss if we use genetic testing?

Propecia (finasteride) is the most-commonly prescribed treatment for men with male pattern hair loss, but when tested scientifically on women with hair loss, the published data was contradictory.  Some studies showed that finasteride was of no benefit for women, but yet several anecdotal reports in the literature appeared which seemed to show that there was some improvement in some female patients.

Over the years at Bauman Medical Group, we've noticed that some women with hair loss who were prescribed Propecia(finasteride) certainly tend to improve while others do not.  Recently, genetic hair loss testing for men has been able to more accurately predict their chances of responding to Propecia (finasteride), so why not a similar test for women? 

A recent discussion with the company who created HairDX, the first non-invasive genetic tests for hair loss, has revealed that pilot studies on women looking specifically at "androgen sensitivity" have been successful in predicting the chances of successful treatment with Propecia (finasteride). Identifying the certain populaton of women suffering from hair loss who also have a high degree of androgen sensitivity can help determine which women are more likely to benefit from medical therapy.  More details regarding the "Androgen Sensitivity Genetic Test For Women" are forthcoming.

Propecia/Finasteride blocks the creation of dihydroestosterone (DHT), a potent androgen found in both men and women and also the known trigger for male pattern hair loss.  Keep in mind that Propecia is FDA-approved for men only and is contraindicated in women of childbearing age due to the potential risk to a developing male fetus.  Use of finasteride in women would be an 'off label' prescription.

For more information on Propecia / Finasteride in the treatment of female hair loss and the NEW Androgen Sensitivity Genetic Test, please contact Dr. Alan J. Bauman at 561-394-0024 or

Dr. Alan J. Bauman, M.D.

Genetic Test Predicts Cellulite... Whatcha Gonna Do About It?

Cellulite: A common concern

As mentioned in a previous post, Genetic Test Predicts Cellulite, a non-invasive genetic test now exists that can predict your chances of suffering from cellulite.  Unfortunately, there is no miracle cure or consistent treatment regimen that exists.   Confirming speculation that cellulite may be related to a circulation or blood supply issue, the genetic test looks at ACE (angiotensin converting enzyme), a cardiovascular enzyme.  The press release alludes to the fact that lifestyle choices, nutrition, medication choices may impact cellulite--and even goes as far to say that treatments such as laser therapy may be effective in slowing or stopping it's progression.


At our Bauman Medical Group in Boca Raton, we've noticed that some women do receive some benefit from Zerona Laser Therapy when it comes to cellulite.  However, it is certainly not every patient, not every time.   Cellulite is a complex 'three dimensional problem' of the skin, altering its appearance and function creating the dreaded "cottage cheese look."   One component may be the amount of fat trapped between the septae within the outermost layers of fat just under the skin.  Reducing the amount of fat in those areas (diet, exercise, laser therapy, etc.) may help the problem.  

Let me know what you think...  If you knew you were going to be prone to cellulite (or more cellulite) what would you do?  What steps would you take...?  How far would you go to prevent it?

--Dr. B.